Navigation Links
New grant empowers young researchers to find a cure for pancreatic cancer
Date:7/30/2013

Bethesda, MD (July 30, 2013) The American Gastroenterological Association (AGA) Research Foundation has announced a gift from the Bernard Lee Schwartz Foundation of $1,125,000 to the foundation's endowment. The AGA Institute will provide matching support, resulting in a $2,250,000 grant dedicated to advancing basic research in pancreatic cancer, the fourth leading cause of cancer deaths in the U.S. This award is in honor of the late businessman and photographer, Bernard Lee Schwartz, who suffered from the disease and died in 1978 at the age of 64.

"Until there is a cure for pancreatic cancer, significant funding must be dedicated to basic research into this devastating disease," said Martin Brotman, MD, AGAF, chair, AGA Research Foundation. "The research funded by the AGA-Bernard Lee Schwartz Designated Research Scholar Award in Pancreatic Cancer will advance our knowledge of the early detection and treatment of pancreatic cancer. The AGA Research Foundation is sincerely thankful to the Bernard Lee Schwartz Foundation for their continued confidence in AGA's research scholars."

The AGA-Bernard Lee Schwartz Designated Research Scholar Award in Pancreatic Cancer will be provided to young researchers interested in developing independent and productive careers in pancreatic cancer. Award recipients will receive $90,000 per year for three years to conduct basic research related to pancreatic cancer. The first recipient will receive his/her first award payment in July 2014 and subsequent awardees will start funding upon conclusion of the current recipient's award term.

Researchers interested in applying for the AGA-Bernard Lee Schwartz Designated Research Scholar Award in Pancreatic Cancer should visit http://www.gastro.org/foundation. The application deadline is Oct. 18, 2013.

This is the Bernard Lee Schwartz Foundation's third contribution to the AGA Research Foundation endowment in honor of their late family member. In 2010, their grant supported Kenneth P. Olive, PhD, from Columbia University, in his research towards identifying better treatment modalities for pancreatic cancer. The first recipient, Kenneth H. Yu, MD, of the University of Pennsylvania, focused his research on identifying screening protein markers associated with pancreatic tumors, which will yield a test to detect the disease at an early stage.

"In order to find a cure for pancreatic cancer, we must continue to provide young, innovative investigators with the resources they need, and enough dedicated time, to focus on basic research," said the Schwartz family. "There will be more than 38,400 deaths from pancreatic cancer in the U.S. in 2013. We hope this award helps to attract the next generation of talented researchers to work towards a cure for this deadly disease."


'/>"/>

Contact: Rachel Steigerwald
media@gastro.org
301-272-1603
American Gastroenterological Association
Source:Eurekalert

Related medicine news :

1. North Shore-LIJ Health System's Feinstein Institute to Receive $250,000 Grant from Lymphoma Research Foundation Grant to support research of Chronic Lymphocytic Leukemia
2. AED.com Releases Exclusive Grant Guide
3. Banner Health, Mayo Clinic receive grant
4. Loyola School of Nursing Online DNP Program Receives Federal Grant for Health Training
5. 2 BUSM faculty receive Alzheimers disease grants
6. Well Community Project Grants $180,000 to Community Organizations in Mississippi, Michigan, and Louisiana to Promote Wellness
7. Colleen’s Dream Foundation's First ‘Young Investigator’ Grant Directed to Dr. Felix Zeppernick of Johns Hopkins University
8. Damon Runyon grants prestigious fellowship awards to 17 top young scientists
9. NIH grant makes STaRs of 8 Wayne State nursing students
10. LSDF announces grants to commercialize health-related products and services
11. BUSMs Anurag Singh, Ph.D., receives top American Lung Association grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... York, NY (PRWEB) , ... April 29, 2016 , ... New York City based oral ... . This surgery is a very effective way to treat obstructive sleep apnea. Dr. Jamali ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This surgery ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market ... funding led by Eastside Partners, with participation from existing investor Martin Ventures. ... and accelerate its technology and product roadmap. , “Jvion is experiencing ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... print media enterprise focused entirely on patients with cancer, today announced that Lynne ... chosen as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... awareness for Duchenne muscular dystrophy, and funding for Duchenne research, participated in the ... of the Sarepta Therapeutic’s novel Duchenne drug eteplirsen. The meeting at the Marriott ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)...  Marking its one year anniversary since launching ... risk test, Color Genomics announced a ... impact the most common hereditary cancers affecting both ... analyzes hereditary cancer risks for breast, colorectal, melanoma, ... Color Test is physician ordered and includes genetic ...
(Date:4/28/2016)... 28, 2016 Dr. Vivek Ahuja ... and Ste phen Schmidt ... leading provider of cloud-based software solutions for life sciences, today announced ... bring a wealth of insight to a growing business.  This will ... George Phillips joined ArisGlobal in the position of ...
Breaking Medicine Technology: